SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chen T, Rimpilainen M, Luukkainen R, Mottonen, T, Yli-Jama T, Jalava J, et al. Bacterial components in the synovial tissue of patients with advanced rheumatoid arthritis or osteoarthritis: analysis with gas chromatography-mass spectrometry and pan-bacterial polymerase chain reaction. Arthritis Rheum (Arthritis Care Res) 2003; 49: 328334.
  • 2
    Toivanen A, Toivanen P. Reactive arthritis. Curr Opin Rheumatol 2000; 12: 3005.
  • 3
    Hyrich KL, Inman RD. Infectious agents in chronic rheumatic diseases. Curr Opin Rheumatol 2001; 13: 3004.
  • 4
    Bas S, Griffais R, Kvien TK, Glennas A, Melby K, Vischer TL. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995; 38: 100513.
  • 5
    Branigan PJ, Gerard HC, Hudson AP, Schumacher HR Jr, Pando J. Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis Rheum 1996; 39: 17406.
  • 6
    Gilbart J, Fox A, Whiton RS, Morgan SL. Rhamnose and muramic acid: chemical markers for bacterial cell walls in mammalian tissues. J Microbiol Methods 1986; 5: 27282.
  • 7
    Christensson B, Gilbart J, Fox A, Morgan SL. Mass spectrometric quantitation of muramic acid, a bacterial cell wall component, in septic synovial fluids. Arthritis Rheum 1989; 32: 126872.
  • 8
    Lehtonen L, Kortekangas P, Oksman P, Eerola E, Aro H, Toivanen A. Synovial fluid muramic acid in acute inflammatory arthritis. Br J Rheumatol 1994; 33: 112730.
  • 9
    Van der Heijden IM, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, Hazenberg MP, et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 2000; 43: 5938.
  • 10
    Pacheco-Tena C, Zhang X, Stone M, Burgos-Vargas R, Inman RD. Innate immunity in host-microbial interactions: beyond B27 in the spondyloarthropathies. Curr Opin Rheumatol 2002; 14: 37382.
  • 11
    Schrijver IA, Melief M-J, Tak PP, Hazenberg MP, Laman JD. Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthritis Rheum 2000; 43: 21608.
  • 12
    Simelyte E, Rimpiläinen M, Lehtonen L, Zhang X, Toivanen P. Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains. Infect Immun 2000; 68: 353540.
  • 13
    Zhang X, Rimpiläinen M, Simelyte E, Toivanen P. Characterization of Eubacterium cell wall: peptidoglycan structure determines arthritogenicity. Ann Rheum Dis 2001; 60: 26974.
  • 14
    Zhang X, Rimpilainen M, Simelyte E, Toivanen P. Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls. Infect Immun 2001; 69: 727784.
  • 15
    Sato S, Takeuchi O, Fujita T, Tomizawa H, Takeda K, Akira S. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol 2002; 14: 78391.
  • 16
    Jacinto R, Hartung T, McCall C, Li L. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol 2002; 168: 613641.
  • 17
    Medvedev AE, Henneke P, Schromm A, Lien E, Ingalls R, Fenton MJ, et al. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J Immunol 2001; 167: 225767.
  • 18
    Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000; 68: 6398401.
  • 19
    Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 18791.
  • 20
    Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, et al. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002; 186: 15225.
  • 21
    Schumacher HR Jr, Gerard HC, Arayssi TK, Pando JA, Branigan PJ, Saaibi DL, et al. Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum 1999; 42: 188993.
  • 22
    Olmez N, Wang GF, Li Y, Zhang H, Schumacher HR. Chlamydial nucleic acids in synovium in osteoarthritis: what are the implications? J Rheumatol 2001; 28: 187480.
  • 23
    Przyklenk B, Bauernfeind A, Bornschein W, Emminger G, Heilmann K, Schweighart S. The role of Campylobacter (Helicobacter) pylori in disorders of the gastrointestinal tract. Infection 1990; 18: 37.
  • 24
    Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, et al. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001; 13: 145765.
  • 25
    Schumacher HR Jr, Magge S, Cherian PV, Sleckman J, Rothfuss S, Clayburne G, et al. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome: immunocytochemical identification of Chlamydial antigen in patients with early disease. Arthritis Rheum 1988; 31: 93746.
  • 26
    Nikkari S, Rantakokko K, Ekman P, Mottonen T, Leirisalo Repo M, Virtala M, et al. Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 1999; 42: 849.
  • 27
    Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomaki O, Pekkola-Heino K, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 21621.
  • 28
    Gerard HC, Wang Z, Wang GF, El-Gabalawy H, Goldbach-Mansky R, Li Y, et al. Chromosomal DNA from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum 2001; 44: 168997.
  • 29
    Pacheco-Tena C, Alvarado De La Barrera C, Lopez-Vidal Y, Vazquez-Mellado J, Richaud-Patin Y, Amieva RI, et al. Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology (Oxford) 2001; 40: 9207.
  • 30
    Braun J, Tuszewski M, Ehlers S, Haberle J, Bollow M, Eggens U, et al. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. II. Examination of sacroiliac and knee joint biopsies of patients with spondyloarthropathies and other arthritides. J Rheumatol 1997; 24: 11015.
  • 31
    Stimpson SA, Esser RE, Cromartie WJ, Schwab JH. Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci. Infect Immun 1986; 52: 3906.
  • 32
    Lehman TJ, Allen JB, Plotz PH, Wilder RL. Lactobacillus casei cell wall-induced arthritis in rats: cell wall fragment distribution and persistence in chronic arthritis-susceptible LEW/N and -resistant F344/N rats. Arthritis Rheum 1984; 27: 93942.
  • 33
    Eisenberg R, Fox A, Greenblatt JJ, Anderle SK, Cromartie WJ, Schwab JH. Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats. Infect Immun 1982; 38: 12735.
  • 34
    Anderle SK, Allen JB, Wilder RL, Eisenberg RA, Cromartie WJ, Schwab JH. Measurement of streptococcal cell wall in tissue of rats resistant or susceptible to cell wall-induced chronic erosive arthritis. Infect Immun 1985; 49: 8367.
  • 35
    Dalldorf FG, Cromartie WJ, Anderle SK, Clark RL, Schwab JH. The relation of experimental arthritis to the distribution of streptococcal cell wall fragments. Am J Pathol 1980; 100: 383402.
  • 36
    Wilder RL, Allen JB, Wahl LM, Calandra GB, Wahl SM. The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum 1983; 26: 144251.
  • 37
    Simelyte E, Rimpiläinen M, Rantakokko K, Lehtonen L, Zhang X, Aho H, et al. Tissue distribution and persistence of arthritogenic and nonarthritogenic Eubacterium cell walls. Clin Exp Rheumatol 1999; 17: 2818.
  • 38
    Gilbart J, Fox A. Elimination of group A streptococcal cell walls from mammalian tissues. Infect Immun 1987; 55: 15268.
  • 39
    Fox A, Schwab JH, Cochran T. Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry. Infect Immun 1980; 29: 52631.